Can Tofacitinib Offer Protection against COVID-19 Infection?

Detalles Bibliográficos
Autores principales: Goldberger, Tal, Zlotogorski, Abraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089460/
https://www.ncbi.nlm.nih.gov/pubmed/34192119
http://dx.doi.org/10.1159/000514364
_version_ 1783687044144300032
author Goldberger, Tal
Zlotogorski, Abraham
author_facet Goldberger, Tal
Zlotogorski, Abraham
author_sort Goldberger, Tal
collection PubMed
description
format Online
Article
Text
id pubmed-8089460
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-80894602021-05-03 Can Tofacitinib Offer Protection against COVID-19 Infection? Goldberger, Tal Zlotogorski, Abraham Skin Appendage Disord Letter S. Karger AG 2021-06 2021-03-23 /pmc/articles/PMC8089460/ /pubmed/34192119 http://dx.doi.org/10.1159/000514364 Text en Copyright © 2021 by S. Karger AG, Basel
spellingShingle Letter
Goldberger, Tal
Zlotogorski, Abraham
Can Tofacitinib Offer Protection against COVID-19 Infection?
title Can Tofacitinib Offer Protection against COVID-19 Infection?
title_full Can Tofacitinib Offer Protection against COVID-19 Infection?
title_fullStr Can Tofacitinib Offer Protection against COVID-19 Infection?
title_full_unstemmed Can Tofacitinib Offer Protection against COVID-19 Infection?
title_short Can Tofacitinib Offer Protection against COVID-19 Infection?
title_sort can tofacitinib offer protection against covid-19 infection?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089460/
https://www.ncbi.nlm.nih.gov/pubmed/34192119
http://dx.doi.org/10.1159/000514364
work_keys_str_mv AT goldbergertal cantofacitinibofferprotectionagainstcovid19infection
AT zlotogorskiabraham cantofacitinibofferprotectionagainstcovid19infection

Ejemplares similares